Entasis Therapeutics is working on novel therapies for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.

PodcastsResourcesAntibioticsBacteriaClinical drug developmentDrug development (Research and development)DrugsEpidemiologyHealth care and economicsInfectious diseasesMedicine, Diagnosis, and TherapeuticsMicrobial drug resistanceMicrobiological phenomenaMicrobiologyMicroorganismsMortalityMultidrug resistancePharmacokineticsPharmacologyPhase II clinical trials (Drug development)Population characteristicPublic healthResearch and developmentSystemic conditions
Previous articleAnimal Models for Neurological Disorders
Next articleLegoChem and Takeda Partner to Evaluate Next-Generation ADCs